Article ID Journal Published Year Pages File Type
8929849 British Journal of Anaesthesia 2018 9 Pages PDF
Abstract
IL-6 is both necessary and sufficient to produce cognitive decline. Following further preclinical testing of its perioperative safety, the IL6R blocker tocilizumab is a candidate for prevention and/or treatment of PND.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Anesthesiology and Pain Medicine
Preview
Interleukin-6 is both necessary and sufficient to produce perioperative neurocognitive disorder in mice
Authors
, , , , , , ,